Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Chatelain

Showing results (301-310 of 306) with videos related to

Pageof 31
Sort By:
You have reached the last page of results.This site can display upto 306 results.
Archives De Pediatrie : Organe Officiel De La Societe Francaise De Pediatrie|April 1, 1994
[Final height in Turner syndrome treated with growth hormone]P Rocchiccioli, J Battin, A M Bertrand, et al.
European Journal of Endocrinology|June 14, 2013
A pharmacogenomic approach to the treatment of children with GH deficiency or Turner syndromeP Clayton, P Chatelain, L Tatò, et al.
Journal of Molecular Endocrinology|October 3, 2013
Network analysis: a new approach to study endocrine disordersA Stevens, C De Leonibus, D Hanson, et al.
The Pharmacogenomics Journal|April 10, 2013
Pharmacogenomics of insulin-like growth factor-I generation during GH treatment in children with GH deficiency or Turner syndromeA Stevens, P Clayton, L Tatò, et al.
Hormone Research|January 21, 2000
Diagnosis of growth hormone (GH) deficiency and the use of GH in children with growth disordersA Juul, S Bernasconi, P Chatelain, et al.
Journal of Medical Genetics|November 6, 2001
Acromicric dysplasia: long term outcome and evidence of autosomal dominant inheritanceL Faivre, M Le Merrer, C Baumann, et al.
Pageof 31

Showing results (301-310 of 306) with videos related to

Sort By:
Pageof 31
You have reached the last page of results.This site can display upto 306 results.
Archives De Pediatrie : Organe Officiel De La Societe Francaise De Pediatrie|April 1, 1994
[Final height in Turner syndrome treated with growth hormone]P Rocchiccioli, J Battin, A M Bertrand, et al.
European Journal of Endocrinology|June 14, 2013
A pharmacogenomic approach to the treatment of children with GH deficiency or Turner syndromeP Clayton, P Chatelain, L Tatò, et al.
Journal of Molecular Endocrinology|October 3, 2013
Network analysis: a new approach to study endocrine disordersA Stevens, C De Leonibus, D Hanson, et al.
The Pharmacogenomics Journal|April 10, 2013
Pharmacogenomics of insulin-like growth factor-I generation during GH treatment in children with GH deficiency or Turner syndromeA Stevens, P Clayton, L Tatò, et al.
Hormone Research|January 21, 2000
Diagnosis of growth hormone (GH) deficiency and the use of GH in children with growth disordersA Juul, S Bernasconi, P Chatelain, et al.
Journal of Medical Genetics|November 6, 2001
Acromicric dysplasia: long term outcome and evidence of autosomal dominant inheritanceL Faivre, M Le Merrer, C Baumann, et al.
Pageof 31